Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma
暂无分享，去创建一个
M. Borad | N. Foster | S. Alberts | R. McWilliams | W. Ma | B. Fruth | A. Mahipal | M. Hartgers | Zhaohui Jin | S. Tella | S. Chakrabarti | Tara L. Hogenson | H. Pitot | Shi-ming Qian | M. Fernandez-Zapico | Leslie Washburn | Jaclynn Wessling | Tran Nguyen